$40.62
-0.29-0.71%
At close: -
$40.65
0.030.07%
After Hours: Jun 17, 4:49 PM EDT
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
SPDR S&P Pharmaceuticals ETF Stock Price, Quotes and Forecasts
XPHARCA
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
148.34M
Fund Score
SPDR S&P Pharmaceuticals ETF Price, Quotes and Forecasts | ARCA:XPH | Benzinga
Explore SPDR S&P Pharmaceuticals ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for XPH.
| Open | $41.13 |
| High | $41.13 |
| 52 Wk High | $48.76 |
| AUM | 148.34M |
| Dividend | $0.62 |
| Ex-Div Date | Jun 24, 2024 |
| Volume | 53.21K |
| Market Cap | $68.69B |
| Mgmt Fee | 0.35% |
| P/E Ratio | 55.82 |
| Prev. Close | $40.91 |
| Low | $40.41 |
| 52 Wk Low | $35.22 |
| Shares Out | 4.85M |
| Yield | 1.48% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 50.77K |
| Beta | 0.76 |
| Avg. Expense Ratio | 0.35% |
| P/B Ratio | 2.22 |
Recent News
FAQ
Q
How do I buy SPDR S&P Pharmaceuticals ETF (XPH) stock?
A
You can purchase shares of SPDR S&P Pharmaceuticals ETF (ARCA:XPH) through any online brokerage.
Q
Who are SPDR S&P Pharmaceuticals ETF (XPH) competitors?
A
There are no as such competitors for SPDR S&P Pharmaceuticals ETF.
Q
What is the forecast, or price target, for SPDR S&P Pharmaceuticals ETF (XPH) stock?
A
There is no analysis for SPDR S&P Pharmaceuticals ETF to provide a consensus price target.
Q
What is the current price for SPDR S&P Pharmaceuticals ETF (XPH)?
A
The stock price for SPDR S&P Pharmaceuticals ETF (ARCA: XPH) is $40.65 last updated June 17, 2025 at 4:49 PM EDT.
Q
Does SPDR S&P Pharmaceuticals ETF (XPH) pay a dividend?
A
A quarterly cash dividend of 0.05 per share of Class A Common Stock. The quarterly cash dividend was payable on September 27, 2018 to stockholders of record on September 24, 2018.
Q
When is SPDR S&P Pharmaceuticals ETF (ARCA:XPH) reporting earnings?
A
SPDR S&P Pharmaceuticals ETF does not have any upcoming earnings scheduled.
Q
Is SPDR S&P Pharmaceuticals ETF (XPH) going to split?
A
There is no upcoming split for SPDR S&P Pharmaceuticals ETF.
| Open | $41.13 |
| High | $41.13 |
| 52 Wk High | $48.76 |
| AUM | 148.34M |
| Dividend | $0.62 |
| Ex-Div Date | Jun 24, 2024 |
| Volume | 53.21K |
| Market Cap | $68.69B |
| Mgmt Fee | 0.35% |
| P/E Ratio | 55.82 |
| Prev. Close | $40.91 |
| Low | $40.41 |
| 52 Wk Low | $35.22 |
| Shares Out | 4.85M |
| Yield | 1.48% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 50.77K |
| Beta | 0.76 |
| Avg. Expense Ratio | 0.35% |
| P/B Ratio | 2.22 |
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Blend |
| Fund Inception | Jun 19, 2006 |
| Managers | Keith Richardson Karl A. Schneider |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Investment Policy
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI).
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| AXSM | Axsome Therapeutics, I... | 3.81% |
| VTRS | Viatris Inc. | 3.82% |
| ITCI | Intra-Cellular Therapi... | 3.60% |
| BMY | Bristol-Myers Squibb C... | 3.65% |
| PFE | Pfizer, Inc. | 3.67% |
| CORT | Corcept Therapeutics I... | 5.67% |
| JNJ | Johnson & Johnson | 3.83% |
| OGN | Organon & Co | 3.55% |
| CTLT | Catalent, Inc. | 3.84% |
| ZTS | Zoetis, Inc. | 4.19% |
| RPRX | Royalty Pharma | 4.02% |
| LLY | Eli Lilly & Co. | 3.61% |
| JAZZ | Jazz Pharmaceuticals P... | 4.19% |
| PRGO | Perrigo Co. Plc | 3.92% |
| TARS | Tarsus Pharmaceuticals... | 4.11% |
| ELAN | Elanco Animal Health I... | 5.20% |
| PBH | Prestige Consumer Heal... | 3.92% |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved